Table 1 Baseline demographic characteristics of the randomised patient population [18].
Variable | Aripiprazole (N = 284) | All SOC (N = 271) | Total (N = 555) |
|---|---|---|---|
Age, years | |||
Mean | 38.1 | 38.8 | 38.5 |
Median | 36.5 | 37.0 | 37.0 |
SE | 10.8 | 11.1 | 10.9 |
Gender, n (%) | |||
Male | 169 (59.5) | 163 (60.1) | 332 (59.8) |
Female | 115 (40.5) | 108 (39.9) | 223 (40.2) |
Race, n (%) | |||
White | 274 (96.5) | 262 (96.7) | 536 (96.6) |
Black | 3 (1.1) | 1 (0.4) | 4 (0.7) |
Asian | 3 (1.1) | 6 (2.2) | 9 (1.6) |
Other | 4 (1.4) | 2 (0.7) | 6 (1.1) |
Weight, kg | |||
Mean | 80.4 | 81.0 | 80.7 |
Median | 79.0 | 79.0 | 79.0 |
SE | 17.5 | 17.0 | 17.2 |
Missing | Â | 2 | 2 |
Schizophrenia type, n (%) | |||
Disorganised | 24 (8.5) | 32 (11.8) | 56 (10.1) |
Catatonic | 3 (1.1) | 4 (1.5) | 7 (13) |
Paranoid | 189 (66.5) | 172 (63.5) | 361 (65.0) |
Residual | 31 (10.9) | 36 (13.3) | 67 (12.1) |
Undifferentiated | 37 (13.0) | 27 (10.0) | 64 (11.5) |
Age at time of first hospitalisation, years | |||
Mean | 28.3 | 28.7 | 28.5 |
Median | 27.0 | 27.0 | 27.0 |
SE | 8.5 | 8.7 | 8.6 |
Missing | 35 | 26 | 61 |
Previous medication, N (%) | |||
Any Antipsychotic Medication* | 273 (96.1) | 267 (98.5) | 540 (97.3) |
Olanzapine | 75 (26.4) | 85 (31.4) | 160 (28.8) |
Quetiapine | 15 (5.3) | 17 (6.3) | 32 (5.8) |
Risperidone | 66 (23.2) | 69 (25.5) | 135 (24.3) |